Home
About
Overview
Sharing Data
ORCID
Help
History (21)
The gap-junction inhibitor carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells.
Peripheral-blood versus bone marrow stem cells.
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.
Epigenome-Microbiome crosstalk: A potential new paradigm influencing neonatal susceptibility to disease.
Manipulating the microbiome to improve the efficacy of immunotherapy.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Manipulating the microbiome to improve the efficacy of immunotherapy.
Manipulating the microbiome to improve the efficacy of immunotherapy. Clin Adv Hematol Oncol. 2016 Jun; 14(6):424-6.
View in:
PubMed
subject areas
Bifidobacterium
Gastrointestinal Microbiome
Humans
Immunity
Immunotherapy
Lymphocytes, Tumor-Infiltrating
Neoplasms
Prognosis
Research
T-Lymphocyte Subsets
Treatment Outcome
authors with profiles
Thomas F. Gajewski